HARDMAN & CO RESEARCH 
15/03/2023 13:15
Divers historique
Hardman & Co Research on H&T (initiation of coverage): Pawnbroking royalty, with strong, profitable growth
Lire la news
HARDMAN & CO RESEARCH 
15/03/2023 08:15
Divers historique
Hardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth
Lire la news
HARDMAN & CO RESEARCH 
14/03/2023 15:05
Divers historique
Hardman & Co Research on Apax Global Alpha (APAX): Outperformance by adding value to companies
Lire la news
HARDMAN & CO RESEARCH 
07/03/2023 08:15
Divers historique
Hardman & Co Research on Pantheon International Plc (PIN): Exceptional companies, long-term outperformance
Lire la news
HARDMAN & CO RESEARCH 
01/03/2023 15:40
Divers historique
Hardman & Co Research: Q&A with Mark Thomas on Real Estate Credit Investments (RECI) 'Opportunities in uncertain times'
Lire la news
HARDMAN & CO RESEARCH 
24/02/2023 17:05
Divers historique
Hardman & Co Q&A on ICG Enterprise Trust plc (ICGT): Defensive growth adding value to investors
Lire la news
HARDMAN & CO RESEARCH 
09/02/2023 15:45
Divers historique
Hardman & Co Research on Real Estate Credit Investments (RECI): Looking at the current opportunities
Lire la news
HARDMAN & CO RESEARCH 
09/02/2023 08:15
Divers historique
Hardman & Co Research on ICG Enterprise Trust Plc (ICGT): 3Q’23: continued growth and resilience
Lire la news
HARDMAN & CO RESEARCH 
27/01/2023 17:53
Divers historique
Hardman & Co Research: Q&A on Advanced Oncotherapy (AVO): Current EV significantly below cumulative investment to date
Lire la news
HARDMAN & CO RESEARCH 
25/01/2023 09:45
Divers historique
Hardman & Co Research on City of London Investment Group: Swings and roundabouts
Lire la news
HARDMAN & CO RESEARCH 
24/01/2023 11:15
Divers historique
Hardman & Co Q&A on Apax Global Alpha (APAX): Adding value to private companies
Lire la news
HARDMAN & CO RESEARCH 
23/01/2023 12:15
Divers historique
Hardman & Co Q&A on Shield Therapeutics (STX): Positioned for profitability with Viatris deal and its additional capital
Lire la news
HARDMAN & CO RESEARCH 
18/01/2023 15:15
Divers historique
Hardman & Co Q&A on Oakley Capital Investments Ltd (OCI): High-growth drivers in 2023
Lire la news
HARDMAN & CO RESEARCH 
17/01/2023 16:10
Divers historique
Hardman & Co Research on Advanced Oncotherapy (AVO): Understanding the significance of 230MeV
Lire la news
HARDMAN & CO RESEARCH 
16/01/2023 08:00
Divers historique
Hardman & Co Research on Cornerstone FS (CSFS): Strong FY22 update and Avila House divestment
Lire la news
HARDMAN & CO RESEARCH 
13/01/2023 12:10
Divers historique
Hardman & Co Research on Apax Global Alpha (Initiation of coverage): Making pearls out of oysters
Lire la news
HARDMAN & CO RESEARCH 
13/01/2023 08:15
Divers historique
Hardman & Co Research: Shield Therapeutics (STX) - Positioned for growth and profitability
Lire la news
HARDMAN & CO RESEARCH 
03/01/2023 17:10
Divers historique
Hardman & Co Research on The Fulham Shore (FUL): Resilient first-half trading
Lire la news
HARDMAN & CO RESEARCH 
22/12/2022 08:00
Divers historique
Hardman & Co Research on Cornerstone FS (CSFS): Pragmatic strategic reset under the new CEO
Lire la news
HARDMAN & CO RESEARCH 
15/12/2022 11:22
Divers historique
Hardman & Co Research : Surface Transforms (SCE): Major OEM 10 order, OEM 8 delay resolved
Lire la news